Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition

Artículo

Open/Download

Treatment-of-systemic.pdf (199.2Kb)

Access note

Acceso a solo metadatos

Publication date

2020

Metadata

Show full item record

Cómo citar

Aguilera, Sergio

Cómo citar

Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibitionFormato de cita APAISO 690-2ChicagoMLAVancouver

.

Copiar

Cerrar



Author

• Aguilera, Sergio;
• Rivera, Diego;
• Barrera, María José;

Indexation

Artículo de publicación ISI

Identifier

URI: https://repositorio.uchile.cl/handle/2250/175289

Quote Item

JCR: Journal of Clinical Rheumatology. 26(3):19, (2020)

Collections

• Artículos de revistas